Trademark: 79250615
Status Date
Tuesday, February 11, 2020
Registration Number
5980170
Registration Date
Tuesday, February 11, 2020
Filing Date
Monday, December 3, 2018
Published for Opposition
Tuesday, November 26, 2019
5 Pharmaceutical and veterinary products, namely, pharmaceutical products for the prevention and treatment of immune system related diseases and disorders, therapeutic vaccines; pharmaceutical preparations, namely, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; medicines for human medicine, namely, medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical pharmaceutical products for the diagnosis and treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; diagnostic preparations for medical use; chemical preparations for pharmaceutical use namely, for diagnosing and treating cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases
1 Chemical, biochemical, biological and biotechnological products intended for industry and science, namely, biological preparations for use in industry and science, diagnostic preparations for clinical and medical laboratory use; chemical, biochemical, biological and biotechnological products, namely, antibodies and antibody particles for development and manufacture of pharmaceutical products; biological products, namely, antibodies and antibody fragments for use in laboratories, diagnosis and analysis for scientific and research purposes; chemical and biochemical additives, supports and substances for the manufacture of pharmaceutical products
42 Research and development in the field of pharmaceutical products, biotechnology, antibodies and antibody fragments, proteins, micro-organisms and cells for therapeutic purposes; research with respect to pharmaceutical products, biotechnology, therapy, antibody and gene therapy; research, product development and quality control in the field of pharmacy, diagnostics and therapy; research in the field of chemistry and biology; industrial analysis and research services in the field of biochemistry and pharmaceuticals; research and development of antibody products for therapeutic purposes; preparing and conducting chemical, biochemical and biotechnological analysis and research
Dec 31, 2023
New Representative At Ib Received
Aug 27, 2021
New Representative At Ib Received
Aug 20, 2021
New Representative At Ib Received
Jun 12, 2020
Final Decision Transaction Processed By Ib
May 27, 2020
Final Disposition Notice Sent To Ib
May 27, 2020
Final Disposition Processed
May 11, 2020
Final Disposition Notice Created, To Be Sent To Ib
Feb 11, 2020
Registered-Principal Register
Nov 26, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 26, 2019
Published For Opposition
Nov 6, 2019
Notification Of Notice Of Publication E-Mailed
Oct 21, 2019
Assigned To Lie
Oct 16, 2019
Approved For Pub - Principal Register
Oct 10, 2019
Examiner's Amendment Entered
Oct 10, 2019
Notification Of Examiners Amendment E-Mailed
Oct 10, 2019
Examiners Amendment E-Mailed
Oct 10, 2019
Examiners Amendment -Written
Sep 20, 2019
Teas/Email Correspondence Entered
Sep 20, 2019
Correspondence Received In Law Office
Sep 20, 2019
Teas Response To Office Action Received
Jun 21, 2019
Change Of Name/Address Rec'd From Ib
Apr 5, 2019
Refusal Processed By Ib
Mar 20, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Mar 20, 2019
Refusal Processed By Mpu
Mar 13, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Mar 12, 2019
Non-Final Action Written
Mar 3, 2019
Assigned To Examiner
Feb 9, 2019
Application Filing Receipt Mailed
Feb 5, 2019
New Application Office Supplied Data Entered
Jan 31, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
